149 related articles for article (PubMed ID: 31670970)
1. Side Chain Optimization Remarkably Enhances the in Vivo Stability of
Chen J; Li C; Hong H; Liu H; Wang C; Xu M; Han Y; Liu Z
Mol Pharm; 2019 Dec; 16(12):5035-5041. PubMed ID: 31670970
[TBL] [Abstract][Full Text] [Related]
2. Alanine and glycine conjugates of (2S,4R)-4-[
Zha Z; Ploessl K; Lieberman BP; Wang L; Kung HF
Nucl Med Biol; 2018 May; 60():19-28. PubMed ID: 29525446
[TBL] [Abstract][Full Text] [Related]
3. PET Imaging of
Liu F; Xu X; Zhu H; Zhang Y; Yang J; Zhang L; Li N; Zhu L; Kung HF; Yang Z
Mol Pharm; 2018 Aug; 15(8):3448-3455. PubMed ID: 29985631
[TBL] [Abstract][Full Text] [Related]
4. PET imaging of glutaminolysis in tumors by 18F-(2S,4R)4-fluoroglutamine.
Lieberman BP; Ploessl K; Wang L; Qu W; Zha Z; Wise DR; Chodosh LA; Belka G; Thompson CB; Kung HF
J Nucl Med; 2011 Dec; 52(12):1947-55. PubMed ID: 22095958
[TBL] [Abstract][Full Text] [Related]
5. Preclinical study of an
Li C; Liu H; Duan D; Zhou Z; Liu Z
Nucl Med Biol; 2018; 64-65():34-40. PubMed ID: 30041148
[TBL] [Abstract][Full Text] [Related]
6. [(18)F](2S,4S)-4-(3-Fluoropropyl)glutamine as a tumor imaging agent.
Wu Z; Zha Z; Li G; Lieberman BP; Choi SR; Ploessl K; Kung HF
Mol Pharm; 2014 Nov; 11(11):3852-66. PubMed ID: 25095908
[TBL] [Abstract][Full Text] [Related]
7. Comparative evaluation of 18F-labeled glutamic acid and glutamine as tumor metabolic imaging agents.
Ploessl K; Wang L; Lieberman BP; Qu W; Kung HF
J Nucl Med; 2012 Oct; 53(10):1616-24. PubMed ID: 22935578
[TBL] [Abstract][Full Text] [Related]
8. PET/MR Imaging of a Lung Metastasis Model of Clear Cell Renal Cell Carcinoma with (2S,4R)-4-[
Pollard AC; Paolillo V; Radaram B; Qureshy S; Li L; Maity T; Wang L; Uddin MN; Wood CG; Karam JA; Pagel MD; Piwnica-Worms D; Millward SW; Fowlkes NW; Norton W; Engel BJ; Pisaneschi F; Zacharias NM
Mol Imaging Biol; 2022 Dec; 24(6):959-972. PubMed ID: 35732988
[TBL] [Abstract][Full Text] [Related]
9. Metabolic Evaluation of MYCN-Amplified Neuroblastoma by 4-[
Li C; Huang S; Guo J; Wang C; Huang Z; Huang R; Liu L; Liang S; Wang H
Mol Imaging Biol; 2019 Dec; 21(6):1117-1126. PubMed ID: 30850970
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of (2S,4S)-4-[
Huang Y; Liu Y; Li C; Li Z; Chen H; Zhang L; Liang Y; Wu Z
Mol Pharm; 2023 Oct; 20(10):5195-5205. PubMed ID: 37647563
[TBL] [Abstract][Full Text] [Related]
11. Automated synthesis of [(18)F](2S,4R)-4-fluoroglutamine on a GE TRACERlab™ FX-N Pro module.
Zhang X; Basuli F; Shi ZD; Xu B; Blackman B; Choyke PL; Swenson RE
Appl Radiat Isot; 2016 Jun; 112():110-4. PubMed ID: 27019029
[TBL] [Abstract][Full Text] [Related]
12. (2S, 4R)-4-[
Miner MW; Liljenbäck H; Virta J; Merisaari J; Oikonen V; Westermarck J; Li XG; Roivainen A
Mol Imaging Biol; 2020 Aug; 22(4):969-978. PubMed ID: 31993927
[TBL] [Abstract][Full Text] [Related]
13. Radiosynthesis, in vitro and preliminary in vivo evaluation of the novel glutamine derived PET tracers [
Baguet T; Verhoeven J; Pauwelyn G; Hu J; Lambe P; De Lombaerde S; Piron S; Donche S; Descamps B; Goethals I; Vanhove C; De Vos F; Beyzavi MH
Nucl Med Biol; 2020; 86-87():20-29. PubMed ID: 32447069
[TBL] [Abstract][Full Text] [Related]
14. Improved stability of a novel fluorine-18 labeled TCO analogue for pretargeted PET imaging.
Ruivo E; Adhikari K; Elvas F; Fissers J; Vangestel C; Staelens S; Stroobants S; Van der Veken P; Wyffels L; Augustyns K
Nucl Med Biol; 2019; 76-77():36-42. PubMed ID: 31707309
[TBL] [Abstract][Full Text] [Related]
15. More advantages in detecting bone and soft tissue metastases from prostate cancer using
Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
[TBL] [Abstract][Full Text] [Related]
16. (2S,4R)-4-[
Zhu H; Liu F; Zhang Y; Yang J; Xu X; Guo X; Liu T; Li N; Zhu L; Kung HF; Yang Z
Mol Imaging Biol; 2019 Oct; 21(5):945-953. PubMed ID: 30793240
[TBL] [Abstract][Full Text] [Related]
17. Exploiting Glutamine Consumption in Atherosclerotic Lesions by Positron Emission Tomography Tracer (2
Palani S; Miner MWG; Virta J; Liljenbäck H; Eskola O; Örd T; Ravindran A; Kaikkonen MU; Knuuti J; Li XG; Saraste A; Roivainen A
Front Immunol; 2022; 13():821423. PubMed ID: 35145523
[TBL] [Abstract][Full Text] [Related]
18. In Vivo PET Assay of Tumor Glutamine Flux and Metabolism: In-Human Trial of
Dunphy MPS; Harding JJ; Venneti S; Zhang H; Burnazi EM; Bromberg J; Omuro AM; Hsieh JJ; Mellinghoff IK; Staton K; Pressl C; Beattie BJ; Zanzonico PB; Gerecitano JF; Kelsen DP; Weber W; Lyashchenko SK; Kung HF; Lewis JS
Radiology; 2018 May; 287(2):667-675. PubMed ID: 29388903
[TBL] [Abstract][Full Text] [Related]
19. Imaging Brain Metastasis Patients With 18F-(2S,4R)-4-Fluoroglutamine.
Xu X; Zhu H; Liu F; Zhang Y; Yang J; Zhang L; Zhu L; Li N; Kung HF; Yang Z
Clin Nucl Med; 2018 Nov; 43(11):e392-e399. PubMed ID: 30179907
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
